Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-12-02T18:06:51.521Z Has data issue: false hasContentIssue false

Limitations to Participation in Opioid Maintenance Treatment in Europe

Published online by Cambridge University Press:  15 April 2020

L. Brandt
Affiliation:
Center for Public Health, Medical University of Vienna, Vienna, Austria
A. Unger
Affiliation:
Department for Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
L. Moser
Affiliation:
Center for Public Health, Medical University of Vienna, Vienna, Austria
G. Fischer
Affiliation:
Department for Psychiatry and Psychotherapy & Center for Public Health, Medical University of Vienna, Vienna, Austria
R. Jagsch
Affiliation:
Faculty of Psychology, University of Vienna, Vienna, Austria

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective

Our aim was to identify areas of improvement for current Opioid Maintenance Treatment (OMT) approaches, by analysing European Quality Audit of Opioid Treatment (EQUATOR) data from 8 European countries (Austria, Denmark, France, Germany, Norway, Portugal, Sweden, UK).

Method

A standardised face-to-face survey was administered to OMT patients (OMT-P) and active opioid user (AOU). Reasons for entering and staying out of OMT, rules pertaining to OMT, and factors facilitating OMT retention were compared between countries, and between OMT-P and AOU groups. Both groups were divided into those who never had OMT before [un-experienced OMT-P (n=573) and AOU (n=360)] and those who had been maintained at least once [experienced OMT-P (n=746) and AOU (n=377)].

Results

Motives for starting OMT vary distinctly between countries (p≤0.001). Transnationally, experienced AOU reported concerns about their ability to follow treatment rules and negative treatment experiences as decisive reasons for staying out of OMT. Greater flexibility, less pressure to reduce their treatment dose and greater treatment structure were ranked significantly higher by experienced compared to un-experienced OMT-P as factors that might facilitate treatment retention (p≤0.05).

Conclusion

The major strength of this investigation was the homogenous methodology applied in all countries, which enabled new insights in variations between treatment systems and their impact on patient outcome. Treatment systems need to aim an optimal balance between flexibility and structure. Standardised approaches that still permit tailoring treatment to individual patient needs are crucial to yield maximum benefit for patients, and reduce the considerable societal economic burden of addiction.

Type
Article: 0513
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.